5 Women to Watch in Boston Biotech

Less than five percent of the CEOs in Fortune 500 companies are women (blameless one is an African-American woman) limit in Boston, several of the greatest in quantity influential biotech executives are women. Perhaps it is the act that startups with at least individual female founder simply perform better. To elevation the accomplishments of these pioneering executives, here’s a snapshot at the contributions of five clever women to biotech in Boston.

Susan Windham-Bannister, President and CEO of Biomedical Growth Strategies and the Managing Partner of Biomedical Innovation Advisors

Susan Windham-Bannister was the ~ and foremost President and CEO of the Massachusetts Life Sciences Center at which place she oversaw a $1 billion investment to accelerate the growth of biotech in Massachusetts. A trail-blazer, she was the ~ and foremost African-American woman to lead a life sciences advancement initiative of this scale. Named single of the 10 Most Influential Women in Biotech ~ the agency of the Boston Globe, Windham-Bannister took the lumbar region at the Massachusetts Life Sciences Center in 2008 at a specifically difficult time in the US regulation. Windham-Bannister turned this potential disservice into a creative force for suitable, partnering with the private sector to, to the degree that a 2013 Northeastern University report form in a mould: “attract $3 in outside investing. for every public dollar spent, bending course just over $300 million in category funds into more than $1 billion excellence of backing for the local life sciences sector.”

Susan Windham-Bannister direction be the keynote for the Women’s Leadership Symposium and Dinner at portion of our Biotech Week Boston end this October.

Mary Lynne Hedley, Ph.D. Co-Founder, President and Board Member, Tesaro

Named “Life Science Entrepreneur of the Year” ~ the agency of the New England Venture Capital Association this farther than spring, Mary Lynne Hedley Ph.D. has been fairly called a pharmacology pioneer as she has been developing cancer drugs considering 1996. Hedley began her career while the co-founder of Zycos, Inc. (which later became MGI Pharma, then Eisai Co Ltd.) pathetic on in 2009 to become EVP of Operations and Chief Scientific Officer of Abraxis Bioscience. In 2010 Hedley co-founded (by partner Lonnie Moulder) Boston biotech Tesaro, some oncology-focused biopharmaceutical company. The chief drug Tesaro brought to the place of traffic, called Varubi, manages the side furniture of chemotherapy to alleviate suffering and accordingly bring some normalcy to the lives of oncology patients. Tesaro is also developing cancer drug Niraparib which we wrote near to here. Late last year, Don Seiffert of Boston Business Journal asked Hedley what it was like being one of a tiny minority of women in biotech. Hedley offered: “It’s probably like being a guy in biotech.” Relatively, that rings steady – biotech is a tough endeavors for anyone, with 9 out of 10 companies that commence clinical trials unable to succeed in bringing those drugs to the place of traffic.

Katrine Bosley, Chief Executive Officer, Editas Medicine

In 2016, smooth the least scientifically minded among us cannot esteem missed the buzz about “CRISPR” technology. Katrine Bosley is at the face row and center of this pioneering technology for example the CEO of Editas Medicine. This June Bloomberg called CRISPR “the genetic tool that command modify humanity” and Editas’ mission is to fortunately use CRISPR to repair genes that suit mutations that cause a broad ar~ of diseases. In 2014, when Bosley joined Editas, Alex Lash called her unit of the “highest profile CEOs of the biotech scene” and her side face has only gotten higher since therefore. Bosley began her career at Alkermes, moved forward to Highland Capital Partners, then Biogen, and soon afterward Adnexus (which was bought by Bristol-Myers Squibb).  In her highest CEO role, Bosley led Avila Therapeutics into a buyout from Celgene. Prior to Editas, from 2013-2014 she was every Entrepreneur in Residence at the Broad Institute. This May, Fast Company wrote: “Five years since this was a medical pipedream…With ~y aggressive timeline and a giant war chest, the Editas CEO may exist the first to treat genetic mutations using CRISPR technology…as quick as next year.”

Hannah Mamuszka, Founder Alva10

You may not have heard of Alva10 – yet – nevertheless I’ll take a bet that you determine soon. From stints at some of the greatest in quantity well known Boston based and Global biotechs – Organogenisis, Takeda and ArQule considered in the state of a researcher and scientist – to well-nigh twelve years as a Director of Pharmaceutical Alliances at Exiqon (antecedently Oncotech) and most recently VP of Business Development at Exosome, Hannah Mamuszka’s career “has evolved based on the intersections of biotechnology and avocation development”. The name of her of recent origin company Alva10 was inspired by Thomas Edison – whose centre name was, of course, Alva. Mamuszka explains: “Edison was ~y amazing inventor and thinker, who contemplation about challenges completely differently than everyone other at the time, and produced radically different results as a product of that mind. With Alva10, we are emphasizing the importance that diagnostics play in personalized, exactness medicine, and approaching that value from a completely divers perspective than anyone else (that I’ve seen) in the toil.” The diagnostics she is talking almost can analyze “both DNA and RNA in a corpuscular liquid biopsy”. This ability to change into another form Big Data into “well validated, broadly distributed diagnostics that are valued in the healthcare system” Mamuszka says is guide to precision medicine being realized.

Barbara Fox, Ph.D. Entrepreneur in Residence at Partners Innovation Fund

With a race spanning almost thirty years that started being of the cl~s who a Professor of Medicine at the University of Maryland and led to her current role to the degree that Founder and CEO of Avaxia Biologics, Barbara Fox has honed her networking skills into a fine art, enabling her companies to be rivals and win in the highly based on competition world of biotech. Prior to Avaxia, Fox was ~y Affiliated Entrepreneur at Oxford Bioscience Partners, preceding that President and Chief Scientific Officer of Recovery Pharmaceuticals (at this time Shire) – a company she founded that develops medicines in favor of the treatment of addiction. Her pristine position after teaching was Senior Scientist at Immulogic Pharmaceuticals in what place she quickly moved from that role into Vice President of Discovery Research. At Immulogic Fox directed programs into vaccine disclosure, allergy, autoimmune disease and substance make an ill use of research.

We are pleased to hold Barbara Fox speak at Biotech Week Boston’s Bioprocessing International Conference and Exhibition. She determine be presenting “Funding a Therapeutic-Focused Company through Angels: The Good, The Bad and the Ugly”. Fox resoluteness also be a panelist for: ”How to Overcome the Funding Gap on account of Biotech Start-ups and Emerging Companies”. Fox resoluteness be joined by Joshua Speidel, Latham Biopharm Group and Ohad Karnieli of Karnieli, Ltd.

Got at all more women in Boston biotech you ponder we need to write about? We’d delight in to share them with our assembly of hearers so Tweet to us at @BiotechWkBoston. And don’t neglect to check in every week because our Biotech Week Boston blog succession. Biotech Week Boston is a nave for life sciences, technology, and duty and fosters cross-disciplinary interaction and collaboration to part down silos and spark change. Biotech Week Boston wish showcase the most comprehensive science and innovative technologies time fostering partnerships to unlock the abounding potential of what science and occupation can achieve. Learn more by clicking the fasten below.

What exactly is #BiotechWeekBoston?

Share this indenture with your social network, just sound with a ~ below to share now!

Share |

F&#959r pattern, &#1091&#959&#965 &#1089&#959&#965&#406&#1281 &#965&#1109&#1077 patches t&#959 h&#1077&#406&#1088 &#1091&#959&#965 free smoking.

Recent Comments